4//SEC Filing
Kaufmann Gunnar F. 4
Accession 0001209191-23-002030
CIK 0001260990other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 6:00 PM ET
Size
4.9 KB
Accession
0001209191-23-002030
Insider Transaction Report
Form 4
Kaufmann Gunnar F.
Chief Scientific Officer
Transactions
- Tax Payment
Common Stock
2023-01-03$1.02/sh−6,266$6,391→ 66,726 total
Footnotes (1)
- [F1]Shares withheld by the Issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units.
Documents
Issuer
Oncternal Therapeutics, Inc.
CIK 0001260990
Entity typeother
Related Parties
1- filerCIK 0001786754
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 6:00 PM ET
- Size
- 4.9 KB